Search by Journal
- HOME
- > Search by Journal
- > Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Annual Meeting of Japanese Association of Cardiovascular Pharmacology
Volume 24, Issue / 2014


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
Having been differentiated by Yamagata cohort study 久保田功 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 18-19, 2014. |
---|
![]() |
Cardiac activity control mechanism by the CCR4-NOT complex stored from S-01 yeast to humans 久場敬司 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 20-20, 2014. |
---|
![]() |
Molecular target medicine-resistant system analysis in S-02 KRas mutation or the BRaf mutation cancer cell 青木一洋 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 22-22, 2014. |
---|
![]() |
The measurement and imaging of the S-03 myocardial metabolism product 佐野元昭 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 24-24, 2014. |
---|
![]() |
Blood vessel functional analysis: by the S-04 fluorescence living body image A smooth muscle contraction and thrombogenesis process 西村智 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 26-26, 2014. |
---|
![]() |
Control structure through the Ca2+ signal crosstalk in the cells of the A-01 myocardium L-form Ca2+ channel 赤羽悟美, 伊藤雅方, 杉本結衣, 関由成 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 30-30, 2014. |
---|
![]() |
Ca2+ activation Cl- channel TMEM16A which functions, and develops in A-02 mouse portal vein smooth-muscle cells 山村寿男, 大城隼也, 近藤るびい, 佐伯尚紀, 鈴木良明, 今泉祐治 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 31-31, 2014. |
---|
![]() |
Conductance Ca2+ activation K+ channel opening medicine DCEBIO out of A-03 low / promotes the line differentiation of C2C12 cells 坂本多穂, 田中翔子, 木村純子 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 32-32, 2014. |
---|
![]() |
A Ca2+ change of the A-04 myocardium type ryanodine receptor (RyR2) arrhythmia original nature mutation and effect on CICR activity 呉林なごみ1), 村山尚1), 太田亮作2), 山下富義2), 鈴木純二3), 金丸和典3), 飯野正光3), 櫻井隆1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 33-33, 2014. |
---|
![]() |
Participation in calcium micro domain formation of mitofusin in the A-05 vascular smooth muscle 川崎桂輔, 鈴木良明, 山村寿男, 今泉祐治 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 34-34, 2014. |
---|
![]() |
Role of the growth factors midkine in the A-06 uremic cardiomyopathy onset 本多勇希, 宍戸哲郎, 高橋徹也, 木下大資, 横山美雪, 門脇心平, 成味太郎, 西山悟史, 高橋大, 有本貴範, 宮本卓也, 渡邉哲, 久保田功 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 35-35, 2014. |
---|
![]() |
A-07 Contribution of endothelial glycocalyx in renal peritubular capillaries in acute kidney injury 中野大介1), Betteridge Kai1),2), Salmon Andrew2), 西山成1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 36-36, 2014. |
---|
![]() |
Role in the heart of A-08 ischemia, reperfusion injury factor TRPM2 沼田朋大1),3), 清水俊一2), 井上隆司1), 森泰生3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 37-37, 2014. |
---|
![]() |
The remote part ischemia conditioning of the A-09 transientness shows a cardioprotection effect through exosome 泉康雄1), 山口雄大2), 岡真優子3), 田中昌子4), 塩田正之1), 葭山稔2), 三浦克之1),4), 岩尾洋1),5) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 38-38, 2014. |
---|
![]() |
Role of mitochondrial GTP-binding protein Drp1 in the myocardium aging instruction of the A-10 infarction nest boundary region 西田基宏1),2),3), 外山喬士1), 北島直幸1),2), 西村明幸1), 冨田拓郎1), 石川達也2),4) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 39-39, 2014. |
---|
![]() |
Molecular mechanism of the cell membrane shift disorder due to the A-11 type I long QT syndrome mutation 稲野辺厚, 都築千鶴, 倉智嘉久 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 40-40, 2014. |
---|
![]() |
Phosphorylation mechanism of ERK1/2 through the transactivation of the PDGF receptor induced by B-01 endothelin -1 堀之内孝広, 星暁壮, 原田拓弥, Karki Sarita, 東恒仁, 寺田晃士, Nepal Prabha, 堀口美香, 三輪聡一 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 41-41, 2014. |
---|
![]() |
Contribution to hyperglycemia-induced ROS production of GRK2 in B-02 humans vascular endothelial cells and β-arrestin2 水野夏実1), 坂田公正1),2), 服部裕一1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 42-42, 2014. |
---|
![]() |
About podocyte protection effect of B-03 HMG-CoA reductase inhibitor pitavastatin and participation of BMP-7 and the mechanism 大東誠, 中田徹男, 小原幸, 鳥羽裕恵 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 43-43, 2014. |
---|
![]() |
Septicemic hasty sex nephropathic mechanism analysis by the B-04 living body real-time imaging 中野大介1), 土井研人2), 西山成1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 44-44, 2014. |
---|
![]() |
The beneficial effect on septicemic mouse of B-05 cardiac restorative levosimendan and the action mecha-nism 坂田公正1),2), 横尾宏毅3), 王強1), 高階道徳1), Lobna A Abedelzaher1), 今泉貴博1), 坂本卓弥1), 大橋若奈1), 芳村直樹2), 服部裕一1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 45-45, 2014. |
---|
![]() |
Participation: of the NO underproductivity in B-06 left ventricular hypertrophy and the cardiovascular procedure death Underlying and clinical knowledge 筒井正人1), 亀崎文彦2),3), 真弓俊彦3), 尾辻豊2) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 46-46, 2014. |
---|
![]() |
B-07 bilirubin makes vascular endothelial cells activate and promotes neovascularisation after ischemia 池田康将1), 金井佑亮1),2), 堀ノ内裕也1), 石澤有紀1), 木平孝高1), 宮本理人3), 石澤啓介4), 土屋浩一郎3), 玉置俊晃1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 47-47, 2014. |
---|
![]() |
Effect on rat aorta blood vessel relaxation due to the B-08 in tiger fat and contractile function 阿曽吉孝1), 小野真太郎2), 片野由美3), 石幡明3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 48-48, 2014. |
---|
![]() |
The effect that a B-09 active oxygen, nitrogen species gives to a blood vessel relaxation response through the NO-sGC-cGMP course 田和正志, 下里貴, 岩崎広高, 今村武史, 岡村富夫 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 49-49, 2014. |
---|
![]() |
Effect of eukaryotic elongation factor 2 kinase (eEF2K) which gives it to B-10 monochromatic thalline-induced rat pulmonary hypertension onset, extension 亀島聡, 風間恭輔, 岡田宗善, 山脇英之 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 50-50, 2014. |
---|
![]() |
The effect that B-11 inflammation and lipid load give to the atrial fibrillation onset 高成広起1), 高橋正起1), 馬芳芳1), 増田季美子1), 近藤秀和2), 森島真幸1), 高橋尚彦2), 小野克重1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 51-51, 2014. |
---|
![]() |
Comparison of the effect of the antiarrhythmic drug on atrium line remodeled B-12 electrically 千葉俊樹1),2), 近藤直人2), 清水直子2), 高原章1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 52-52, 2014. |
---|
![]() |
Participation of the inflammasome in the B-13 atrial fibrillation onset 笹渕航平1), 目時莉沙1), 松下尚子2), 高橋将文3), 谷口俊一郎4), 弘瀬雅教1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 53-53, 2014. |
---|
![]() |
stanniocalcin 1 is involved in cardiotoxicity of B-14 sorafenib 西村有平1),2),3),4),5), 川端美湖1),6), 梅本紀子1), 島田康人1), 黒柳淳哉1), 張貝貝1), 宮部雅幸6), 田中利男1),2),3),4),5) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 54-54, 2014. |
---|
![]() |
Effect of the cigarette smoke extract which gives it to B-15 platelet aggregation 柏木仁1), 結城幸一1), 小島史章1), 粂井志麻1), 成宮周2), 牛首文隆1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 55-55, 2014. |
---|
![]() |
Role of the proton in the transmission between the B-16 rat mesenterial artery blood vessel neighborhood nerve 川崎博己, 高取真吾 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 56-56, 2014. |
---|
![]() |
Establishment of the new shrinkage analytical method of the flying fortress standstill type stellate cell of liver 若林夢人, 西山良太, 齊藤真也, 石川智久 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 57-57, 2014. |
---|
![]() |
Clinical examination about molecular treatment in the B-18 metastasis-related renal carcinoma with target medicine and the arteriosclerotic lesion progress 一柳統1), 高井諭1), 内藤整1), 牛島正毅1), 八木真由1), 櫻井俊彦1), 谷内田優季1), 山岸敦史1), 黒田悠太1), 西田隼人1), 柴崎智宏1), 川添久1), 福原宏樹2), 中山尚子1), 成澤貴史1),3), 加藤智幸1), 長岡明1), 冨田善彦1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 58-58, 2014. |
---|
![]() |
Shrinkage responsiveness aggravates the sole artery of the chronic strangulation model rat of the B-19 sciatic nerve by a Ca2+ discharge disorder through NCX 石田裕丈, 古川琢麻, 齊藤真也, 石川智久 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 59-59, 2014. |
---|
![]() |
Function promotion effect of antianginal drugs nicorandil for B-20 heart type Na/Ca exchanger (NCX1) 渡邊泰秀1), 韋嘉章2), 竹内和彦2), 山下寛奈1), 田代美由紀1), 喜多紗斗美3), 岩本隆宏3), 渡邉裕司2), 木村純子4) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 60-60, 2014. |
---|
![]() |
About the possibility that B-21 azelnidipine modifies Cav1.2 channel quantitatively 那須史明1), 倉上和也1),2), 石井邦明1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 61-61, 2014. |
---|
![]() |
The YIA-01 AT1 angiotensin H receptor /β arrestin 2 bias signal makes the L-form Ca2+ channel of feebleness cardiac muscle cells activate through activation of α' beta type casein kinase 2 柏原俊英, 中田勉, 郭暁光, 山田充彦 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 64-64, 2014. |
---|
![]() |
Heart failure exacerbation effect mechanism by YIA-02 Haloperidol 篠田康晴, 田頭秀章, 福永浩司 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 65-65, 2014. |
---|
![]() |
Astrocytic cerebral blood flow control structure analysis by the Ca2+ imaging in the living body of the YIA-03 cerebral blood vessel smooth muscle 北島奈美1), 関谷敬1), 金丸和典1), 田中謙二2), 飯野正光1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 66-66, 2014. |
---|
![]() |
Analysis of the cardiac muscle cells enlargement mechanism using the YIA-04 HDAC3 selective inhibitor 刀坂泰史1),2),3), 小山内崇人1), 永井陽介1), 砂川陽一1),2),3), 鈴木秀敏1), 和田啓道2), 長谷川浩二2), 森本達也1),3) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 67-67, 2014. |
---|
![]() |
A proarrhythmic effect by the YIA-05 antipsychotics paliperidone: Examination using the acute AV block rabbit 萩原美帆子, 高田一唐, 神林隆一, 渋田成二, 高原章 Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 68-68, 2014. |
---|
![]() |
PGD2 produced by YIA-06 cancer vascular endothelial cells inhibits neovascularisation 大森啓介1), 有竹浩介2), 裏出良博2), 村田幸久1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 69-69, 2014. |
---|
![]() |
A PIP2 of the TRPM4 channel which YIA-07 arrhythmia type mutation E7K causes-sensitive change and active sthenia mechanism 胡耀鵬1), 岡村康司2), 森誠之3), 井上隆司1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 70-70, 2014. |
---|
![]() |
Examination of the effect of statin using the YIA-08 new drug-induced aortic dissection model 石澤有紀1), 石澤啓介2),3), 長尾朋子4), 戸谷紘基4), 小原佑介4), 細岡真由子4), 高田真衣4), 木平孝高1), 池田康将1), 土屋浩一郎4), 玉置俊晃1) Annual Meeting of Japanese Association of Cardiovascular Pharmacology 24: 71-71, 2014. |
---|